We are international
Donate
• about myeloma TEXT SIZE   
Myeloma Treatment Options

Thalidomide is classified as an immunomodulatory agent, which means it affects the levels of certain chemicals in the body that control the activity of cells.

General Information
Clinical Trials
Patient Assistance
Publications
Videos
News
REVLIMID®/THALOMID® TIP CARD
This handy tip card includes indications, dosage, and potential side effects.
Celgene's Patient Support Coordinator Program
Celgene's Patient Support Coordinators assist patients and healthcare providers to navigate the challenges of reimbursement, provide information about co-pay assistance, and answer general questions about Revlimid.

THALOMID®
Celgene's website for Thalomid® with information on clinical information, prescribing guidelines, benefits and risks, etc.